b'Featuring a discussion on recent data with PARP inhibitors in the treatment of breast, ovarian, pancreatic and prostate cancer with Drs Hope Rugo, Ursula Matulonis, Philip A Philip and Maha Hussain, moderated by Neil Love, MD.'